Unknown

Dataset Information

0

Cdk2 strengthens the intra-S checkpoint and counteracts cell cycle exit induced by DNA damage.


ABSTRACT: Although cyclin-dependent kinase 2 (Cdk2) controls the G1/S transition and promotes DNA replication, it is dispensable for cell cycle progression due to redundancy with Cdk1. Yet Cdk2 also has non-redundant functions that can be revealed in certain genetic backgrounds and it was reported to promote the G2/M DNA damage response checkpoint in TP53 (p53)-deficient cancer cells. However, in p53-proficient cells subjected to DNA damage, Cdk2 is inactivated by the CDK inhibitor p21. We therefore investigated whether Cdk2 differentially affects checkpoint responses in p53-proficient and deficient cell lines. We show that, independently of p53 status, Cdk2 stimulates the ATR/Chk1 pathway and is required for an efficient DNA replication checkpoint response. In contrast, Cdk2 is not required for a sustained DNA damage response and G2 arrest. Rather, eliminating Cdk2 delays S/G2 progression after DNA damage and accelerates appearance of early markers of cell cycle exit. Notably, Cdk2 knockdown leads to down-regulation of Cdk6, which we show is a non-redundant pRb kinase whose elimination compromises cell cycle progression. Our data reinforce the notion that Cdk2 is a key p21 target in the DNA damage response whose inactivation promotes exit from the cell cycle in G2.

SUBMITTER: Bacevic K 

PROVIDER: S-EPMC5647392 | biostudies-literature | 2017 Oct

REPOSITORIES: biostudies-literature

altmetric image

Publications

Cdk2 strengthens the intra-S checkpoint and counteracts cell cycle exit induced by DNA damage.

Bačević Katarina K   Lossaint Gérald G   Achour Thiziri Nait TN   Georget Virginie V   Fisher Daniel D   Dulić Vjekoslav V  

Scientific reports 20171018 1


Although cyclin-dependent kinase 2 (Cdk2) controls the G1/S transition and promotes DNA replication, it is dispensable for cell cycle progression due to redundancy with Cdk1. Yet Cdk2 also has non-redundant functions that can be revealed in certain genetic backgrounds and it was reported to promote the G2/M DNA damage response checkpoint in TP53 (p53)-deficient cancer cells. However, in p53-proficient cells subjected to DNA damage, Cdk2 is inactivated by the CDK inhibitor p21. We therefore inves  ...[more]

Similar Datasets

| S-EPMC545827 | biostudies-other
| S-EPMC2899860 | biostudies-literature
| S-EPMC4054289 | biostudies-literature
| S-EPMC434231 | biostudies-literature
| S-ECPF-GEOD-39297 | biostudies-other
2014-04-07 | E-GEOD-39297 | biostudies-arrayexpress
| S-EPMC5700845 | biostudies-literature
| S-EPMC2995296 | biostudies-literature
2014-04-07 | GSE39297 | GEO
| S-EPMC10652759 | biostudies-literature